Esophageal Stricture Clinical Trial
Official title:
Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures
In this study the investigators investigate the feasibility and therapeutic potential of free autologous fat grafting combined to dilation therapy in the treatment of benign esophageal strictures.
In this study the investigators wish to proof the concept of free fat graft transfer into esophageal stricture via flexible video gastroscope.The investigators will recruit twenty patients suffering from (endoscopy proven) benign stricture of the esophagus. The Eckardt score is recorded upon recruitment and one day before operation. The operation is performed at the gastroenterology outpatient clinic in Turku University Hospital by a gastrointestinal surgeon. The patient is sedated with alfentanil and midazolam. First, abdominal liposuction (roughly 20 ml) is performed under local infiltration anesthesia. The fat graft is processed into nano-fat using Tulip GEMS Single-Use NanoTransfer Set. Esophagoscopy with gastroscope is performed and stricture is visually graded (location, length, lumen) and photographed. Then esophageal stricture is biopsied with biopsy forceps and dilated with through-the-scope CRE(controlled radial expansion) balloon dilator. Prepared fat graft is injected beneath the mucosal layer at the stricture site (volume of 0,1-0,5 ml) at three locations. Patients are either discharged after two hours follow up or admitted to the inpatient ward, depending on the pre- and postoperative condition. Patients are contacted by phone 1 week after the operation. Post-operative symptoms are recorded and patients are requested to contact the researcher if needed. Patient records are screened for pre- and postoperative symptoms, medication, long term illnesses and possible postoperative contacts to hospital. Follow-up esophagoscopy is performed and biopsies taken three and 12 months after the first operation. The stricture site is visually graded and photographed. The Eckardt score is recorded. If the patient has problems with eating (Eckardt score dysphagia points more than 1) the stricture is re-dilated and fat grafting repeated. If a patient would have recurrence in dysphagia before three months the patient is treated according to normal routine and dilation is repeated earlier. The follow-up time is 12 months counting from the last fat grafting. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04372784 -
Cryoablation for Benign Gastrointestinal Anastomotic Strictures
|
N/A | |
| Recruiting |
NCT05581173 -
Self-Assembling Matrix Forming Gel to Prevent Stricture Formation
|
||
| Recruiting |
NCT04406428 -
NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures
|
N/A | |
| Recruiting |
NCT00551824 -
Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children
|
N/A | |
| Completed |
NCT04284826 -
Mitomycin-C Injection Therapy in Refractory Esophageal Stricture
|
N/A | |
| Terminated |
NCT03898661 -
Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures
|
Early Phase 1 | |
| Withdrawn |
NCT04730076 -
Balloon Dilation Methods for Benign Esophageal Stricture
|
N/A | |
| Active, not recruiting |
NCT03885310 -
INGEST I Pilot Study
|
N/A | |
| Completed |
NCT02069847 -
Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy
|
Phase 2 | |
| Completed |
NCT03039608 -
Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm
|
N/A | |
| Terminated |
NCT02354716 -
EndoFLIP Use in Upper GI Tract Stenosis
|
||
| Recruiting |
NCT05561114 -
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
|
Phase 3 | |
| Not yet recruiting |
NCT04524897 -
The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children
|
Phase 4 |